Search Results

Weight-loss drugs and your heart.

Subjects: MYOCARDIAL infarction risk factors; ANTIOBESITY agents; APPETITE depressants

• Source: Harvard Heart Letter. May2015, Vol. 25 Issue 9, p5-5. 1p.

Record details

Obesity blockers.

• Authors : Novak, Sara

Subjects: OBESITY; WEIGHT loss; ANTIOBESITY agents

• Source: New Scientist; 5/7/2022, Vol. 254 Issue 3385, p46-49, 4p, 3 Color Photographs

Record details

Both naltrexone‐bupropion and weight loss therapy effective for binge eating disorder.

Subjects: NALTREXONE; DRUG efficacy; OBESITY

• Source: Brown University Psychopharmacology Update. Feb2023, Vol. 34 Issue 2, p4-5. 2p.

Record details

Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial.

• Authors : Nissen, Steven E.; Wolski, Kathy E.; Prcela, Lisa

Subjects: CARDIOVASCULAR disease related mortality; OBESITY complications; BLOOD pressureUNITED States

• Source: JAMA: Journal of the American Medical Association. 3/8/2016, Vol. 315 Issue 10, p990-1004. 15p.

Record details

Integrating obesity medicines in the national list of essential medicines: a policy concern.

• Authors : Sindhwani, Ritika; Bora, Kundan Singh; Hazra, Subhajit

Subjects: PESTICIDE resistance; DRUG side effects; ANTIOBESITY agents

• Source: Current Science (00113891); 9/25/2024, Vol. 127 Issue 6, p660-661, 2p

Record details

Understanding new weight-loss drugs: A class of drugs called GLP-1 receptor agonists can help with weight loss in people who live with obesity or type 2 diabetes. But are they suitable for other people?

Subjects: OBESITY; FOOD security; TYPE 2 diabetes

• Source: Harvard Men's Health Watch. Nov2023, Vol. 28 Issue 4, p4-5. 2p.

Record details

Review of the pharmacologic arsenal for the war on obesity.

• Authors : Derbyshire, Mary Beth; Shek, Allen; Szkotak, Jonathan

Subjects: SYMPATHOMIMETIC agents; ORLISTAT; EXENATIDE

• Source: Formulary. Apr2013, Vol. 48 Issue 4, p136-143. 8p.

Record details

Data on FDA-approved weight management medications dominate Obesity Week.

• Authors : TANZI, MARIA G.

Subjects: *CONFERENCES & conventions; PREVENTION of obesity; REGULATION of body weight

• Source: Pharmacy Today. May2015, Vol. 21 Issue 5, p36-37. 2p.

Record details

Weight Loss Drugs 2005.

Subjects: DRUGS; WEIGHT loss; ANTIOBESITY agents

• Source: Nutrition & Weight Control for Longevity. Jan2005, p74-75. 2p.

Record details

Weight Loss Drugs 2004.

Subjects: WEIGHT loss; ANTIDEPRESSANTS; APPETITE depressants

• Source: Nutrition & Weight Control for Longevity. Jan2004, p76-77. 2p. 1 Chart.

Record details